Search
Now showing items 1-1 of 1
New developments in the treatment of multiple myeloma – <br />clinical utility of daratumumab
(Dove Medical Press Ltd., 2017-04-01)
Multiple myeloma is a clonal disorder of plasma cells that is currently considered incurable. CD38 is a 46 kDa type II transmembrane glycoprotein that is highly expressed on myeloma cells. Daratumumab is a first in-class ...